Clinical Trials Directory

Trials / Completed

CompletedNCT06819787

Patient Experiences With Contraceptive Care Provided by Community Pharmacists Using the Pharmacist Resource to Implement Services as Modules Platform

Patient-Reported Outcomes of Contraceptive Services Rendered by Community Pharmacists Using the Pharmacist Resource to Implement Services as Modules Platform: The PRISM-CS Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
75 (actual)
Sponsor
OvaryIt, LLC · Industry
Sex
Female
Age
18 Years – 51 Years
Healthy volunteers
Not accepted

Summary

Hormonal contraceptives are medications that require a prescription, traditionally from a physician or advanced practice provider. Over the past decade, pharmacists have gained the authority to prescribe contraceptives in many states, allowing patients to access these medications directly in pharmacies without first seeing another healthcare provider. The Pharmacist Resource to Implement Services as Modules (PRISM) is an Electronic Health Record platform designed to streamline workflows and provide clinical decision support, making it easier and safer to deliver clinical services in community pharmacies. This pilot study will evaluate patient-reported outcomes for women receiving contraceptive services from pharmacists using the PRISM platform at five community pharmacies across the United States over a 12-week period. The study will assess the quality of care, contraception continuation and failure rates, side effect rates, preventative healthcare utilization, and overall patient experience with pharmacy contraceptive services.

Conditions

Interventions

TypeNameDescription
OTHERElectronic Heath Record Platform to Support Pharmacists in Delivering Contraceptive ServicesAn electronic health record (EHR) platform specifically designed to support community pharmacists in delivering contraceptive services. The platform streamlines clinical workflows, provides clinical decision support, and promotes adherence to the US Medical Eligibility Criteria (USMEC) guidelines and state regulatory requirements.

Timeline

Start date
2025-07-12
Primary completion
2025-11-01
Completion
2026-01-31
First posted
2025-02-11
Last updated
2026-02-04

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06819787. Inclusion in this directory is not an endorsement.